In the BioHarmony Drug Report Database

"Preview" Icon

Paricalcitol

Paricalcitol, Zemplar (paricalcitol) is a small molecule pharmaceutical. Paricalcitol was first approved as Paricalcitol on 1998-04-17. It is used to treat hyperparathyroidism in the USA. The pharmaceutical is active against vitamin D3 receptor.

 

Trade Name

 

Paricalcitol, Zemplar
 

Common Name

 

paricalcitol
 

ChEMBL ID

 

CHEMBL1200622
 

Indication

 

hyperparathyroidism
 

Drug Class

 

Vitamin D analogues

Image (chem structure or protein)

Paricalcitol structure rendering